Considering these findings, the monitoring of GDF-15 levels alongside traditional markers like CRP, complete blood counts, or fecal calprotectin could offer a more comprehensive assessment of the inflammatory status in IBD patients, thereby enhancing the disease management strategies. This evidence concerns the gene GDF15 and inflammatory bowel disease.